Celldex Therapeutics, Inc. (NASDAQ:CLDX)

CAPS Rating: 2 out of 5

A biopharmaceutical company engaged in the discovery, development and commercialization of products that harness the human immune response to prevent and treat disease.

Recs

0
Player Avatar pchop123 (79.43) Submitted: 2/5/2013 8:56:21 PM : Outperform Start Price: $7.87 CLDX Score: +5.65

more successlikely near term from positive trial results

Featured Broker Partners


Advertisement